GAMEFILM-Changing the Game for Heart Health
Image

CardioNow Has Partnered With Heartflow To Tackle Cardiovascular Disease

Make the Play That Matters Most

Up to 1 in 3 of former NFL players die from cardiovascular disease,1 yet much remains unknown about how this silent threat impacts so many of these high-performing athletes.

Traditional methods of assessing heart health are good at predicting risk in broad populations, but fail at predicting risk for an individual. CardioNow Analysis goes beyond traditional tests by identifying different types of plaque in your coronary arteries — including those most likely to cause a cardiac event — and measuring the effect on blood flow to your heart.

Contact Us
Image

Changing the Game for Heart Health

GAMEFILM is a groundbreaking heart health study for former NFL players. As a participant, you will receive advanced heart imaging with physician consultations at no cost — helping to shape future prevention and care for yourself and other athletes like you.

With your participation, the data from this study will drive new insights into the unique heart challenges faced by former players, paving the way for earlier detection, better care and stronger standards — for athletes today and for generations to come.

Join the GAMEFILM Registry to Protect the
Hearts That Power The Players

JOIN THE GAMEFILM REGISTRY
Image

Why Choose Coronary CTA (CCTA) + CardioNow

CCTA + CardioNow offers a better way to see inside your heart. This non-invasive test provides a personalized model of your heart, showing if there are blockages as well as plaque buildup to understand your risk of a heart attack.

  • Accurate: Conventional methods of testing for coronary artery disease (CAD), like stress tests, miss disease in 1 of 3 patients and send 55% of patients to unnecessary invasive procedures.2
  • Predictive: CCTA can help detect early signs of heart disease and prevent heart attacks3 by showing plaque buildup in your arteries.
  • Safe: Getting a CCTA scan is a non-invasive procedure, with no anesthesia involved.

See a Step-by-Step CCTA Scan

Go Beyond the Scan with CardioNow Analysis

CardioNow uses the images from your CCTA to create a personalized 3D model of your arteries. Our technology measures how well blood flows and identifies different types of plaque and areas of concern. CardioNow’s AI-driven technologies have helped healthcare providers diagnose CAD and guide treatment decisions for more than 500,000 patients and are recognized by the American Heart Association and the American College of Cardiologists guidelines.5
Image

Plaque Analysis

Shows the amount, type, and location of plaque in your arteries to guide your personalized treatment plan. Plaque Analysis can identify higher-risk plaques that do not appear on a calcium score scan and are most likely to cause a cardiac event.3

Image

FFRCT Analysis

Provides a personalized, color-coded 3D model of your coronary arteries, measuring how disease buildup may be impacting blood flow. This provides the most accurate diagnosis of CAD.4

Your CCTA + CardioNow Experience

Scan

Detailed images of your heart are taken with a non-invasive Coronary CTA.

Measure

The CCTA images undergo advanced AI processing to generate a personalized, 3D model of your arteries.

Act

After your images are processed, you will receive a consultation with a doctor.

CardioNow Has Partnered With Heartflow To Tackle Cardiovascular Disease

heartflow logo

Register Today to Join GAMEFILM

  1. Venkataramani AS, Gandhavadi M, Jena AB. Association between playing American football… JAMA. 2018;319:800–806. https://doi.org/10.1001/jama.2018.0140
  2. Patel, Manesh R., et al. “Low diagnostic yield of elective coronary angiography.” New England Journal of Medicine, vol. 362, no. 10, 11 Mar. 2010, pp. 886–895, https://doi.org/10.1056/nejmoa0907272.
  3. Williams, Michelle C., et al. “Low-Attenuation SCOT-HEART Trial.“ pp. 1452-1462, https://doi.org/10.1161/CIRCULATIONAHA.119.044720
  4. Driessen RS, et al. PACIFIC Substudy. JACC 2019;73(2):161-73. doi.org/10.1016/j.jacc.2018.10.056
  5. Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E., Bhatt, D. L., Birtcher, K. K., … & Weinstock, B. (2021). 2021 AHA/ACC guideline for the evaluation and diagnosis of chest pain: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 144(22), e368-e454. https://doi.org/10.1161/CIR.0000000000001029

Schedule a Consultation With Our Expert Cardiologists

Contact Us Today